MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)

Conditions:   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease Interventions:   Drug: Pegcetacoplan (APL-2);   Other: Placebo Sponsor:   Apellis Pharmaceuticals, Inc. Recruiting

Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials